FDA re­vis­es 1999 draft guid­ance on pop­u­la­tion phar­ma­co­ki­net­ics

The FDA on Thurs­day re­leased re­vised draft guid­ance to help keep spon­sors in­formed on the da­ta and mod­el re­quire­ments for pop­u­la­tion phar­ma­co­ki­net­ics (PK) analy­ses sub­mit­ted as part of new drug ap­pli­ca­tions and bi­o­log­ic li­cense ap­pli­ca­tions.

Since the orig­i­nal pop­u­la­tion PK guid­ance was pub­lished in 1999, the FDA says the num­ber of ap­pli­ca­tions rel­e­vant for pop­u­la­tion PK analy­sis has in­creased and, “The so­phis­ti­ca­tion and re­li­a­bil­i­ty of pop­u­la­tion PK analy­sis meth­ods have im­proved.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER